ATAI Life Sciences NV (ATAI)
1.71
-0.15
(-8.06%)
USD |
NASDAQ |
May 17, 16:00
1.71
0.00 (0.00%)
Pre-Market: 20:00
ATAI Life Sciences Total Liabilities (Quarterly): 45.86M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 45.86M |
December 31, 2023 | 49.16M |
September 30, 2023 | 39.71M |
June 30, 2023 | 37.96M |
March 31, 2023 | 40.08M |
December 31, 2022 | 39.68M |
September 30, 2022 | 46.52M |
Date | Value |
---|---|
June 30, 2022 | 28.81M |
March 31, 2022 | 29.38M |
December 31, 2021 | 28.21M |
September 30, 2021 | 21.35M |
June 30, 2021 | 21.07M |
March 31, 2021 | 25.27M |
December 31, 2020 | 16.18M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
16.18M
Minimum
Dec 2020
49.16M
Maximum
Dec 2023
33.52M
Average
33.67M
Median
Total Liabilities (Quarterly) Benchmarks
Affimed NV | 43.50M |
InflaRx NV | 13.32M |
MorphoSys AG | 2.186B |
BioNTech SE | 2.471B |
Immatics NV | 272.50M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 269.12M |
Shareholders Equity (Quarterly) | 222.54M |